Australia - English - Department of Health (Therapeutic Goods Administration)

sentry medical pty ltd - 34083 - biochemically-interactive dressing - sterile activated carbon cloth medical wound dressing intended for wound healing by secondary intent.

Australia - English - Department of Health (Therapeutic Goods Administration)

sentry medical pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

3m australia pty ltd - 47503 - dressing, biochemically interactive, antimicrobial - promogran prisma matrix is a topically applied interactive wound therapy. the product is a sterile, freeze dried, composite of oxidised regenerated cellulose(orc), collagen and silver-orc, (a compound of silver and orc). in the presence of exudate the promogran prisma matrix transforms into a soft and conformable, biodegradable gel, this allows contact with all areas of the wound. indicated for the management of all wounds healing by secondary intent which are clear of necrotic tissue including: ? diabetic ulcers ? venous ulcers ? pressure ulcers ? ulcers caused by mixed vascular aetiologies ? traumatic and surgical wounds promogran prisma matrix has known haemostatic properties. promogran prisma matrix can be used under compression therapy.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

meril diagnostics pvt ltd, india - biochemistry analyzer -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

shandong horse international co ltd, china - biochemistry analyzer -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

masr trading & industries ltd, tanzania - chemistry reagents -

Ireland - English - HPRA (Health Products Regulatory Authority)

biochem ltd - levamisole hydrochloride, rafoxanide - oral suspension - unknown - levamisole, combinations - bovine, ovine - endoparasiticide

Ireland - English - HPRA (Health Products Regulatory Authority)

biochem ltd - levamisole hydrochloride ; rafoxanide - oral suspension - 15,22.5 milligram(s)/millilitre - levamisole, combinations - cattle, sheep - endoparasiticide

Australia - English - Department of Health (Therapeutic Goods Administration)

william a cook australia pty ltd - 34083 - biochemically-interactive dressing - oasis extracellular matrix is derived using a process that retains the natural composition of matrix molecules. it functions by binding to the receptors on the cells to activate cellular processes, such as replication and growth factor secretion. oasis extracellular matrix is indicated for the management of wounds including: ? partial and full-thickness wounds ? pressure ulcers ? venous ulcers ? chronic vascular ulcers ? diabetic ulcers ? second-degree burns ? third-degree burns ? trauma wounds (abrasions, lacerations, skin tears) ? donor sites/grafts ? draining wounds ? surgical wounds (post-mohs? surgery, post-laser surgery, podiatric, wound dehiscence)

Singapore - English - HSA (Health Sciences Authority)

i med asia pte. ltd. - clinical chemistry - it is intended to be used for the in vitro quantitative determination of alanine aminotransferase(alt),aspartate aminotransferase(ast), alkaline phosphatase(alp), γ- glutamyl transpeptidase(ggt), total bilirubin(tbil), albumin(alb), total protein (tp),glucose(glu),creatinine(crea), total cholesterol(chol), triglyceride(trig), and high density lipoprotein cholesterol(hdl), amylase(amy) and blood urea nitrogen(bun) in serum, plasma, lithium-heparinized whole blood.